Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	9.33	12.54	11.47
Graham Fair Price	-73.89	3.77	14.43
PEG	2413.77	-0.83	0.03
Price/Book	10.78	1.28	1.16
Price/Cash Flow	133.92	92.32	39.47
Prices/Earnings	1530.26	77.12	4.73
Price/Sales	15.62	6.90	5.97
Price/FCF	133.92	92.32	39.47
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.68	0.39	0.38
Operating Margin	0.75	0.36	0.36
ROA	-93.03	< 0.005	0.03
ROE	0.06	< 0.005	-93.20
ROIC	0.03	0.03	-7.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	978.71
Dividends QOQ	-0.02	0.60	3079.26
EBIT QOQ	-0.27	-0.04	86.05
EPS QOQ	1.43	-0.93	-35.15
FCF QOQ	1.50	-0.53	-64.71
Revenue QOQ	-0.13	-0.04	65.42
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.52	5.73	62.98
Days Sales Outstanding (DSO)	28.27	34.09	20.60
Inventory Turnover	25.59	15.70	-38.64
Debt/Capitalization	0.43	0.42	-1.13
Quick Ratio	1.01	0.98	-2.52
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.30	12.32	0.16
Cash	1.54	1.38	-10.48
Capex	-1.50	-1.19	20.37
Free Cash Flow	0.36	0.17	-52.57
Revenue	2.39	2.29	-4.03
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.14	1.04	-9.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.98	4.06	2.01
Naive Interpretation	Member

06 - Financial Health · Bad

Rating